secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001818382-25-000080
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte shareholders approve authorized shares increase to 350M, elect directors
--------------------------------------------------------------------------------

- Authorized common shares raised from 250M to 350M; vote 82.6M for, 14.1M against.
- Four Class I directors elected: Dougan, Green, Seimetz, Wallace (each with >56M votes).
- PwC ratified as auditor for FY2025 (95.3M for, 2.0M against, 0.6M abstain).
- Annual meeting quorum 63.1% (97.9M of 155.1M shares outstanding present).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000181838225000080/0001818382-25-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000181838225000080/huma-20250610.htm
  HTML page:      https://secwatch.observer/filing/0001818382-25-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer